Introduction: Along with the efficacy and safety of drugs, the interaction of drugs with each other and with other accompanying substances is important, too. There are no data about the interaction or influence of antacids and other drugs with polyvalent cations on the metronidazole bioavailability. The purpose of this research was the studying of the metronidazole release kinetics from the tablets in an environment that simulates stomach conditions with the addition of metal salts, which are part of the widespread drugs. The research was conducted to assess the impact of possible interactions between the active substance and polyvalent metal cations on their bioavailability and efficacy.
Material and Methods: Metronidazole tablets were chosen as research object. 0.1 N HCl solution with addition of metal salts was chosen as medium dissolution. The `PharmaTest-DT70` Device with basket, the `Evolution 60S` Spectrophotometer as well as the `AB 204 S/A METTLER TOLEDO` analytical balances were used in the study.
Results: Research of chemical interaction between metronidazole and metal salts, which are part of the widespread drugs, in the experiment `in vitro` was carried out. Metal salts don`t influence the metronidazole release from the tablets, as evidenced by dissolution profiles and similarity factors for each of the cases.
Conclusions: The chemical interactions between the chosen medicines were not observed in the `in vitro` experiment. Thus, separate intake of metronidazole with other drugs, containing metal cations, is important for further research in the `in vivo` experiment.
European Pharmacopoeia. Available from: http://online6.edqm.eu/ep802/
FDA/CDER. Guidance for industry. Waiver of In vivo bioavailability and bioequivalence studies for immediate- release solid oral dosage forms based on a biopharmaceutics classification system, 2000. Available from: http://www.fda.gov/cder/guidance/index.htm
Georgiyants VA, Golovchenko OS, Myhal AV. Investigation of the interaction of metronidazole with metal salts in a weakly alkaline medium. Priorities of pharmacy and stomatology: from theory to practice: proceedings of the II scientific-practical conference (Almaty, 2013). 2013:16-17 (in Russian).
Georgiyants VA, Golovchenko OS, Myhal AV, Khokhlova N.O. Research of interaction of metronidazole with metal salts. Belgorod State University. Scientific bulletin. Medicine. Pharmacy. 2015;4 (201). Issue 29: p 215-219 (in Russian).
Georgiyants VA, Golovchenko OS, Myhal AV. The study of the interaction of metronidazole with antacids. The Clinical pharmacy: 20 years in Ukraine: materials National Congress (March 21-22, 2013, Kharkiv). 2013:57 (in Ukrainian).
Guide 42-7.1:2014. Guidelines on Clinical Research. Drugs. Investigation of Bioavailability. Kyiv:MPHU;2014 (in Ukrainian).
Ivashkin VT, Lapina TL, et al. Rational pharmacotherapy of diseases of the digestive system. Moscow:Literra; 2003 (in Russian).
Metronidazole. Compendium OnLine 2015. Available from: http://compendium.com.ua/akt/77/939/metronidazolum (in Ukrainian).
Migal AV, Khokhlova NO, Dobrova AO, Golovchenko OS, Georgiyants VA. Pharmaceutical preparation and iron salts interaction research. Actual questions of development of new drugs : book of abstracts of XX international scientific and practical conference of young scientists and students, devoted to the 90th anniversary of doctor of science in pharmacy, professor Dmitri Pavlovych Salo (April 25-26, 2013, Kharkiv). 2013:88. (in English)
Myhal AV, Golovchenko OS, Georgiyants VA. Stady of interaction of metronidazole with metal salts. Ukrainian contest of students' scientific works on a “Chemical technology” direction: a collection of conference abstracts (March 20-21, 2014, Dnipropetrovsk). 2014:17 (in Ukrainian).
Nazarova ES, Bobrytskaya L.A. The kinetics of dissolution of drugs with ornidazole. Management, economics and quality assurance in pharmacy. 2012;4:13–18 (in Ukrainian).
State Pharmacopoeia of Ukraine. SOE “Scientific-and-expert Pharmacopeial Centre”. 1st ed. 1st supplement. Kharkiv: SOE “Scientific-and-expert Pharmacopeial Centre”; 2004. (in Ukrainian).
State Pharmacopoeia of Ukraine. SOE “Scientific-and-expert Pharmacopeial Centre”. 1st ed. 2nd supplement. Kharkiv: SOE “Scientific-and-expert Pharmacopeial Centre”; 2007. (in Ukrainian).
State Pharmacopoeia of Ukraine. SOE “Scientific-and-expert Pharmacopeial Centre”. 1st ed. 4th supplement. Kharkiv: SOE “Scientific-and-expert Pharmacopeial Centre”; 2011. (in Ukrainian).
Strachunsky LS, Belousiva JB, Kozlov SN. Practical Guide to antiinfectious chemotherapy. Available from: http://www.antibiotic.ru/ab/061-62.shtml (in Russian).
Ulselan. Compendium OnLine. 2015. Available from: http://compendium.com.ua/info/211021/world-medicine/ulsepan (in Ukrainian).
Unified clinical protocols of primary, secondary (specialized) medical care for peptic ulcer of the stomach and duodenum in adults. Available from: http://www.dec.gov.ua/mtd/_peptychvyrazka.html (in Ukrainian).
United States Pharmacopeia 26. USP Convention Inc. Rockville, 2007. (in English)
Zupanets IA, Chernykh VP, Kupnovytska IG, Popov SB, Bezugla NP, Grintsov YeF, et al. Clinical pharmacy. Kharkiv: Golden pages; 2013 (in Ukrainian).
WHO Expert Committee on Specifications for Pharmaceutical Preparations. WHO Technical Report Series, No. 937, Annex 8. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; World Health Organization: Geneva.
Email this article (Login required) 
